Biotech firm LifeCycle Pharma prepares IPO  

2006.10.19
Danish biotech firm LifeCycle Pharma is preparing an IPO on Copenhagen Stock Exchange
Danish biotech firm LifeCycle Pharma is preparing an IPO on Copenhagen Stock Exchange. The news follows hot on the heels of LifeCycle Pharma's announcement that it has entered two development and commercialisation agreements with global pharmaceutical companies Sandoz Inc and Merck Generics. Stock market analysts expect the IPO to take place this year.
 
Morgan Stanley and Danske Markets are financial advisors to LifeCycle Pharma. If the company goes ahead with an IPO, the capital raised will be used to finance further development of its products towards commercialisation. LifeCycle Pharma currently has six product candidates in clinical development and expects to launch its first product on the US market at the beginning of  2008.
 
LifeCycle Pharma is based in Hørsholm north of Copenhagen. The company utilizes its proprietary Meltdose technology to improve the bioavailability of known and established compounds so that patients can absorb them more effectively. The news was reported by financial daily newspaper Børsen
 
Link > LifeCycle Pharma  

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×